Browse by Journal Title

Article

Novel Clostridium perfringens enterotoxin suicide gene therapy for selective treatment of claudin-3- and -4-overexpressing tumors.
Walther, W. and Petkov, S. and Kuvardina, O.N. and Aumann, J. and Kobelt, D. and Fichtner, I. and Lemm, M. and Piontek, J. and Blasig, I.E. and Stein, U. and Schlag, P.M.
Gene Therapy 19 (5): 494-503. May 2012

The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptor.
Jin, Z. and Maiti, S. and Huls, H. and Singh, H. and Olivares, S. and Mates, L. and Izsvak, Z. and Ivics, Z. and Lee, D.A. and Champlin, R.E. and Cooper, L.J.
Gene Therapy 18 (9): 849-856. September 2011

Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study.
Westermann, J. and Floercken, A. and Willimsky, G. and van Lessen, A. and Kopp, J. and Takvorian, A. and Joehrens, K. and Lukowsky, A. and Schoenemann, C. and Sawitzki, B. and Pohla, H. and Frank, R. and Doerken, B. and Schendel, D.J. and Blankenstein, T. and Pezzutto, A.
Gene Therapy 18 (4): 354-363. April 2011

In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine.
Cayeux, S. and Bukarica, B. and Buschow, C. and Charo, J. and Bunse, M. and Doerken, B. and Blankenstein, T.
Gene Therapy 14 (20): 1481-1491. October 2007

Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles.
Reuß, S. and Biese, P. and Cosset, F.L. and Takeuchi, Y. and Uckert, W.
Gene Therapy 14 (7): 595-603. April 2007

A sensitive noninvasive method for monitoring successful liver-directed gene transfer of the low-density lipoprotein receptor in Watanabe hyperlipidemic rabbits in vivo.
Tietge, U.J.F. and Cichon, G. and Buettner, C. and Genschel, J. and Heeren, J. and Gielow, P. and Grewe, N. and Dogar, M. and Beisiegel, U. and Manns, M.P. and Lochs, H. and Burchert, W. and Schmidt, H.H.J.
Gene Therapy 11 (7): 574-580. April 2004

Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization.
Westermann, J. and Nguyen-Hoai, T. and Mollweide, A. and Richter, G. and Schmetzer, O. and Kim, H.J. and Blankenstein, T. and Doerken, B. and Pezzutto, A.
Gene Therapy 11 (13): 1048-1056. 1 January 2004

Titer determination of Ad5 in blood: a cautionary note.
Cichon, G. and Boeckh-Herwig, S. and Kuemin, D. and Hoffmann, C. and Schmidt, H.H. and Wehnes, E. and Haensch, W. and Schneider, U. and Eckhardt, U. and Burger, R. and Pring-Akerblom, P.
Gene Therapy 10 (12): 1012-1017. June 2003

Coexpression of p21WAF1/CIP1 in adenovirus vector transfected human primary hepatocytes prevents apoptosis resulting in improved transgene expression.
Wolff, G. and Schumacher, A. and Nuessler, A.K. and Ruppert, V. and Karawajew, L. and Wehnes, E. and Neuhaus, P. and Doerken, B.
Gene Therapy 10 (8): 668-677. April 2003

Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes.
Scholz, C. and Staerck, L. and Willimsky, G. and Blankenstein, T. and Doerken, B. and Daniel, P.T.
Gene Therapy 9 (21): 1438-1446. November 2002

Complement activation by recombinant adenoviruses.
Cichon, G. and Boeckh-Herwig, S. and Schmidt, H.H. and Wehnes, E. and Mueller, T. and Pring-Akerblom, P. and Burger, R.
Gene Therapy 8 : 1794-1800. 1 December 2001

MHC class II presentation of endogenously expressed antigens by transfected dendritic cells.
Diebold, S.S. and Cotten, M. and Koch, N. and Zenke, M.
Gene Therapy 8 (6): 487-493. 1 January 2001

Nonviral in vivo gene delivery into tumors using a novel low volume jet-injection technology.
Walther, W. and Stein, U. and Fichtner, I. and Malcherek, L. and Lemm, M. and Schlag, P.M.
Gene Therapy 8 (3): 173-180. 1 January 2001

Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse.
Schendel, D.J. and Frankenberger, B. and Jantzer, P. and Cayeux, S. and Noessner, E. and Willimsky, G. and Maget, B. and Pohla, H. and Blankenstein, T.
Gene Therapy 7 (23): 2007-2014. 1 December 2000

Ovine adenovirus vectors mediate efficient gene transfer to skeletal muscle.
Loeser, P. and Hillgenberg, M. and Arnold, W. and Both, G.W. and Hofmann, C.
Gene Therapy 7 : 1491-1498. 1 September 2000

Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approach.
Brand, K. and Loeser, P. and Arnold, W. and Bartels, T. and Strauss, M.
Gene Therapy 5 : 1363-1371. 1 October 1998

Baculovirus-mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement system.
Hofmann, C. and Strauss, M.
Gene Therapy 5 (4): 531-536. 1 April 1998

Transient immunosuppression with 15-deoxyspergualin prolongs reporter gene expression and reduces humoral immune response after adenoviral gene transfer.
Cichon, G. and Strauss, M.
Gene Therapy 5 : 85-90. 1 January 1998

Retroviral interleukin-7 gene transfer into human dendritic cells enhances T cell activation.
Westermann, J. and Aicher, A. and Qin, Z. and Cayeux, S. and Daemen, K. and Blankenstein, T. and Doerken, B. and Pezzutto, A.
Gene Therapy 5 : 264-271. 1 January 1998

Loss of retroviral gene expression in bone marrow reconstituted mice correlates with down regulation of gene expression in long term culture initiating cells.
Lange, C. and Blankenstein, T.
Gene Therapy 4 : 303-308. 1 January 1997

Employment of the mdr1 promoter for the chemotherapy-inducible expression of therapeutic genes in cancer gene therapy.
Walther, W. and Wendt, J. and Stein, U.
Gene Therapy 4 : 544-552. 1 January 1997

H1 and HMG17 extracted from calf thymus nuclei are efficient DNA carriers in gene transfer.
Zaitsev, S.V. and Haberland, A. and Otto, A. and Vorob'ev, V.I. and Haller, H. and Boettger, M.
Gene Therapy 4 : 586-592. 1 January 1997

HBV-derived promoters direct liver-specific expression of an adenovirally transduced LDL receptor gene.
Sandig, V. and Loeser, P. and Lieber, A. and Kay, M.A. and Strauss, M.
Gene Therapy 3 (11): 1002-1009. October 1996

Effect of amniotic fluid on cationic lipid mediated transfection and retroviral infection.
Douar, A.M. and Themis, M. and Sandig, V. and Friedmann, T. and Coutelle, C.
Gene Therapy 3 (9): 789-796. September 1996

A continuous intracerebral gene delivery system for in vivo liposome mediated gene therapy.
Zhu, J. and Zhang, L. and Hanisch, U.K. and Felgner, P.L. and Reszka, R.
Gene Therapy 3 (6): 472-476. June 1996

Review

Utilization of synthetic peptides containing nuclear localization signals for nonviral gene transfer systems.
Cartier, R. and Reszka, R.
Gene Therapy 9 (3): 157-167. 1 February 2002

Liver-directed gene therapy: prospects and problems.
Strauss, M.
Gene Therapy 1 (3): 156-164. 1 May 1994

Editorial

Conditional gene expression: Intelligent designs.
Gossen, M.
Gene Therapy 13 (17): 1251-1252. September 2006

Cancer vaccines in gene therapy.
Blankenstein, T. and Qin, Z.
Gene Therapy 3 (2): 95-96. 1 January 1996